$DCBG

Dime Commercial Bancshares, Inc. /NY/ (DCBG): Results of Operations and Financial Condition

Dime Commercial Bancshares, Inc. /NY/ (DCBG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 dcom-20260723xex99d1.htm EX-99.1 Page 1 Exhibit 99.1 ​ ​ ​ ​ Dime Commercial Bancshares, Inc. Reports 17% Year-Over-Year Increase in EPS ​ Net Interest Margin Expansion Drives Record Quarterly Revenue of $126 million; Strong Year-Over-Year Core Deposit and Business Loan

Original reporting
Published Jul 23, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 11:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DCBG
Bullish
medium confidence
Mentioned
$DCBG
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DCBGBullishMed
01

Why it matters

The combination of record quarterly revenue, NIM expansion, improved efficiency, and a stated intention to resume share repurchases in Q3 provides a clear catalyst set for re-rating and near-term positioning.

02

Market read

Traders can update models for earnings power (NIM, efficiency, loan/deposit growth) and capital return timing (buybacks starting in Q3) based on today’s filing.

03

What to watch

CRE concentration is cited as lower, but traders may still focus on the trajectory of credit quality beyond the reported 0.46% non-performing assets and the sustainability of NIM through 2027 repricing.

Relevance 7/10Novelty 7/10Timing: Q2 results filed today, with buybacks expected to begin in Q3.

Background

The filing is an SEC 8-K with Exhibit 99.1 reporting Q2 2026 results and capital return plans for Dime Commercial Bancshares.

Company-level read

Ticker impact

$DCBGBullishMedium confidence
Context

Dime Commercial Bancshares reported Q2 net income of $33.0M, EPS $0.75, NIM up to 3.28%, and plans to resume share buybacks in Q3.

Expected impact

Moderately positive bias for the next few sessions as traders price in improved earnings power and capital return timing.

Evidence & confidence

The filing provides multiple fresh operating datapoints (NIM, efficiency, deposits, loans, non-performing assets) and a specific capital action expectation (buybacks starting in Q3), which are actionable for positioning.

Market effects

Adds another data point that smaller commercial banks are benefiting from deposit growth and net interest margin expansion.

Limited, but may influence sentiment toward Northeast US community/commercial banks with similar CRE exposure management.

Low; primarily a US regional bank-specific capital and earnings update.

Counterpoint

Buyback expectations may be contingent on ongoing capital, credit performance, and regulatory constraints, so the market may over-discount the timing.

Key entities

  • Dime Commercial Bancshares, Inc.

    Reported Q2 2026 results, highlighted NIM expansion and deposit/business loan growth, and expects to begin share buybacks in Q3.

  • Dime Commercial Bank

    Operating bank referenced in the re-brand and growth plan context.

  • Kroll Bond Rating Agency

    Issued a “Positive” ratings outlook for Dime, cited as supportive of capital and funding sentiment.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.